β-catenin and cyclin D1 expression in human hepatocellular carcinoma

Oncology Reports

Volumn 9, Issue 6, 2002, Pages 1197-1203

  Ueta, Tsuyoshi ^a   Ikeguchi, Masahide ^a   Hirooka, Yasuaki ^a   Kaibara, Nobuaki ^a   Terada, Tadashi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Exon 3; Immunohistochemistry; Mutation

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; CYCLIN D1; CYTOSKELETON PROTEIN; DNA; HEPATITIS B SURFACE ANTIGEN; KI 67 ANTIGEN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIVISION; ENZYME IMMUNOASSAY; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CYCLIN D1; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; TRANS-ACTIVATORS;

EID: 0036835977     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.6.1197     Document Type: Article

References (34)

1. Murray CJL and Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349: 1269-1276, 1997. (Pubitemid 27192468)
2. Jou TS, Stewart DB, Stappert J, Nelson WJ and Marrs JA: Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 92: 5067-5071, 1995.
3. Larabell CA, Torres M, Rowning BA, Yost C, Miller JR, Wu M, Kimelman D, et al: Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in beta catenin that are modulated by the Wnt signaling pathway. J Cell Biol 136: 1123-1136, 1997. (Pubitemid 27131743)
4. Funayama N, Fagotto F, McCrea P and Gumbiner BM: Embryonic axis induction by the armadillo repeat domain of βcatenin: evidence for intracellular signaling. J Cell Biol 128: 959-968, 1995.
5. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
6. Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P: Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050, 1995.
7. Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, et al: Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene 18: 4044-4046, 1999. (Pubitemid 29361344)
8. Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P, Degott C, et al: Close correlation between β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 18: 6583-6588, 1999.
9. Oda H, Imai Y, Nakatsuru Y, Hata J and Ishikawa T: Somatic mutations of the APC gene in sporadic hepatoblastomas. Cancer Res 56: 3320-3323, 1996. (Pubitemid 26242983)
10. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, et al: Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58: 2524-2527, 1998. (Pubitemid 28275419)
11. De La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, et al: Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sei USA 95: 8847-8851, 1998. (Pubitemid 28350577)
12. Ogawa K, Yamada Y, Kishibe K, Ishizaki K and Tokusashi Y: β-Catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas by diethylnitrosamine in B6C3F1 mice. Cancer Res 59: 1830-1833, 1999. (Pubitemid 29186151)
13. Kondo Y, Kanai Y, Sakamoto M, Genda T, Mizokami M, Ueda R and Hirohashi S: β-Catenin accumulation and mutation of exon 3 of the β-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res 90: 1301-1309, 1999. (Pubitemid 30032067)
14. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL and Peng SY: β-Catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Path 157: 763-770, 2000.
15. Van Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES and Buendia MA: Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Path 155: 703-710, 1999. (Pubitemid 29426815)
16. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999. (Pubitemid 29234650)
17. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, et al: Beta-catenin, a novel prognostic marker for breast cancer: its role in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266, 2000. (Pubitemid 30226121)
18. Tetsu O and McCormick: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
19. Xiong Y, Connolly T, Futcher B and Beach D: Human D-type cyclin. Cell 65: 691-699, 1991.
20. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF and Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559-1571, 1993. (Pubitemid 23234349)
21. Pagano M, Theodoras AM, Tam SW and Draetta G: Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 8: 1627-1639, 1994. (Pubitemid 24236242)
22. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, et al: Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54: 3107-3110, 1994. (Pubitemid 24208910)
23. Edmondson HA and Steiner PE: Primer carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503, 1954.
24. International Union Against Cancer (UICC): TNM classification of malignant tumors. Sobin LH and Wittekind CH (eds). Wiley Liss, New York, pp74-77, 1997.
25. Liver Cancer Study Group of Japan: The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. Kanehara & Co., Ltd., Tokyo, pp16-19, 1992.
26. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ and Allen RC: Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48: 137-144, 1991. (Pubitemid 21903036)
27. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG and Kemler R: Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3-10, 1996. (Pubitemid 26325455)
28. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, et al: Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280: 596-599, 1998.
29. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, et al: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250, 2000. (Pubitemid 30132191)
30. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984. (Pubitemid 14035254)
31. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, et al: Identification of c-MYC as a target of the APC Pathway. Science 281: 1509-1512, 1998. (Pubitemid 28425575)
32. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, et al: Target genes of β-catenin- T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96: 1603-1608, 1999. (Pubitemid 29098498)
33. Saito Y and Ogawa K: Wild-type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1). Oncogene 11: 1013-1018, 1995.
34. Yuen MF, Wu PC, Lai VC, Lau JY and Lai CL: Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma. Cancer 91: 106-112, 2001. (Pubitemid 32052620)